Login / Signup
Sumon Mukherjee
ORCID
Publication Activity (10 Years)
Years Active: 2022-2023
Publications (10 Years): 4
Top Topics
Poor Prognosis
Rna Seq
Dna Repair
Regulatory T Cells
Top Venues
Cancer immunology research
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Subhadip Pati
,
Sumon Mukherjee
,
Saikat Dutta
,
Aharna Guin
,
Dia Roy
,
Sayantan Bose
,
Silpita Paul
,
Sudipto Saha
,
Sankar Bhattacharyya
,
Pratyush Datta
,
Jayati Chakraborty
,
Diptendra K Sarkar
,
Gaurisankar Sa
Tumor-Associated CD19+CD39- B Regulatory Cells Deregulate Class-Switch Recombination to Suppress Antibody Responses.
Cancer immunology research
11 (3) (2023)
Subhadip Pati
,
Sumon Mukherjee
,
Saikat Dutta
,
Aharna Guin
,
Dia Roy
,
Sayantan Bose
,
Silpita Paul
,
Sudipto Saha
,
Sankar Bhattacharyya
,
Pratyush Datta
,
Jayati Chakraborty
,
Diptendra K Sarkar
,
Gaurisankar Sa
Tumor-Associated CD19+CD39- B Regulatory Cells Deregulate Class-Switch Recombination to Suppress Antibody Responses.
Cancer immunology research
11 (3) (2023)
Subhadip Pati
,
Sumon Mukherjee
,
Saikat Dutta
,
Aharna Guin
,
Dia Roy
,
Sayantan Bose
,
Silpita Paul
,
Sudipto Saha
,
Sankar Bhattacharyya
,
Pratyush Datta
,
Jayati Chakraborty
,
Diptendra K Sarkar
,
Gaurisankar Sa
Tumor-Associated CD19+CD39- B Regulatory Cells Deregulate Class-Switch Recombination to Suppress Antibody Responses.
Cancer immunology research
11 (3) (2023)
Subhadip Pati
,
Sumon Mukherjee
,
Saikat Dutta
,
Aharna Guin
,
Dia Roy
,
Sayantan Bose
,
Silpita Paul
,
Sudipto Saha
,
Sankar Bhattacharyya
,
Pratyush Datta
,
Jayati Chakraborty
,
Diptendra K Sarkar
,
Gaurisankar Sa
Tumor-associated CD19+CD39- B regulatory cells deregulate class-switch recombination to suppress antibody responses.
Cancer immunology research
(2022)